Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

Borwin Bandelow; Leo Sher; Robertas Bunevicius; Eric Hollander; Siegfried Kasper; Joseph Zohar; Hans Jürgen Möller; Florence Thibaut; Wioletta Baranska-Rybak; Wieclaw J. Cubala; David Fiellin; Henry R. Kranzler; Alison Moore; Elmars Rankans; Jill Rasmussen; Richard Saitz; Djea Saravane; Thomas E. Schlaepfer; S. W. Tang; Leonas Valius; David Wong; Larisa M. Zhitnikova; C. Allgulander; J. Ayuso-Gutierrez; D. Baldwin; R. Bunevicius; G. Cassano; N. Fineberg; L. Gabriels; I. Hindmarch; H. Kaiya; D. F. Klein; M. Lader; Y. Lecrubier; J. P. Lepine; M. R. Liebowitz; J. J. Lopez-Ibor; D. Marazitti; E. C. Miguel; K. S. Oh; M. Preter; R. Rupprecht; M. Sato; V. Starcevic; D. J. Stein; M. Van Ameringen; J. Vega

doi:10.3109/13651501.2012.667114

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

Borwin Bandelow, Leo Sher, Robertas Bunevicius, Eric Hollander, Siegfried Kasper, Joseph Zohar, Hans Jürgen Möller, Florence Thibaut, Wioletta Baranska-Rybak, Wieclaw J. Cubala, David Fiellin, Henry R. Kranzler, Alison Moore, Elmars Rankans, Jill Rasmussen, Richard Saitz, Djea Saravane, Thomas E. Schlaepfer, S. W. Tang, Leonas ValiusDavid Wong, Larisa M. Zhitnikova, C. Allgulander, J. Ayuso-Gutierrez, D. Baldwin, R. Bunevicius, G. Cassano, N. Fineberg, L. Gabriels, I. Hindmarch, H. Kaiya, D. F. Klein, M. Lader, Y. Lecrubier, J. P. Lepine, M. R. Liebowitz, J. J. Lopez-Ibor, D. Marazitti, E. C. Miguel, K. S. Oh, M. Preter, R. Rupprecht, M. Sato, V. Starcevic, D. J. Stein, M. Van Ameringen, J. Vega

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Review article › peer-review

339 Scopus citations

Abstract

Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessivecompulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.

Original language	English (US)
Pages (from-to)	77-84
Number of pages	8
Journal	International Journal of Psychiatry in Clinical Practice
Volume	16
Issue number	2
DOIs	https://doi.org/10.3109/13651501.2012.667114
State	Published - Jun 2012

Keywords

Anxiety disorders
Generalized anxiety disorder
Guidelines
Panic disorder
Pharmacological treatment
Social anxiety disorder

ASJC Scopus subject areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/13651501.2012.667114

Cite this

Bandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H. J., Thibaut, F., Baranska-Rybak, W., Cubala, W. J., Fiellin, D., Kranzler, H. R., Moore, A., Rankans, E., Rasmussen, J., Saitz, R., Saravane, D., Schlaepfer, T. E., Tang, S. W., ... Vega, J. (2012). Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice, 16(2), 77-84. https://doi.org/10.3109/13651501.2012.667114

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. / Bandelow, Borwin; Sher, Leo; Bunevicius, Robertas et al.
In: International Journal of Psychiatry in Clinical Practice, Vol. 16, No. 2, 06.2012, p. 77-84.

Research output: Contribution to journal › Review article › peer-review

Bandelow, B, Sher, L, Bunevicius, R, Hollander, E, Kasper, S, Zohar, J, Möller, HJ, Thibaut, F, Baranska-Rybak, W, Cubala, WJ, Fiellin, D, Kranzler, HR, Moore, A, Rankans, E, Rasmussen, J, Saitz, R, Saravane, D, Schlaepfer, TE, Tang, SW, Valius, L, Wong, D, Zhitnikova, LM, Allgulander, C, Ayuso-Gutierrez, J, Baldwin, D, Bunevicius, R, Cassano, G, Fineberg, N, Gabriels, L, Hindmarch, I, Kaiya, H, Klein, DF, Lader, M, Lecrubier, Y, Lepine, JP, Liebowitz, MR, Lopez-Ibor, JJ, Marazitti, D, Miguel, EC, Oh, KS, Preter, M, Rupprecht, R, Sato, M, Starcevic, V, Stein, DJ, Van Ameringen, M & Vega, J 2012, 'Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care', International Journal of Psychiatry in Clinical Practice, vol. 16, no. 2, pp. 77-84. https://doi.org/10.3109/13651501.2012.667114

@article{d253a56d5d2c498f8bef61b2a10b1c56,

title = "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care",

abstract = "Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessivecompulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.",

keywords = "Anxiety disorders, Generalized anxiety disorder, Guidelines, Panic disorder, Pharmacological treatment, Social anxiety disorder",

author = "Borwin Bandelow and Leo Sher and Robertas Bunevicius and Eric Hollander and Siegfried Kasper and Joseph Zohar and M{\"o}ller, {Hans J{\"u}rgen} and Florence Thibaut and Wioletta Baranska-Rybak and Cubala, {Wieclaw J.} and David Fiellin and Kranzler, {Henry R.} and Alison Moore and Elmars Rankans and Jill Rasmussen and Richard Saitz and Djea Saravane and Schlaepfer, {Thomas E.} and Tang, {S. W.} and Leonas Valius and David Wong and Zhitnikova, {Larisa M.} and C. Allgulander and J. Ayuso-Gutierrez and D. Baldwin and R. Bunevicius and G. Cassano and N. Fineberg and L. Gabriels and I. Hindmarch and H. Kaiya and Klein, {D. F.} and M. Lader and Y. Lecrubier and Lepine, {J. P.} and Liebowitz, {M. R.} and Lopez-Ibor, {J. J.} and D. Marazitti and Miguel, {E. C.} and Oh, {K. S.} and M. Preter and R. Rupprecht and M. Sato and V. Starcevic and Stein, {D. J.} and {Van Ameringen}, M. and J. Vega",

year = "2012",

month = jun,

doi = "10.3109/13651501.2012.667114",

language = "English (US)",

volume = "16",

pages = "77--84",

journal = "International Journal of Psychiatry in Clinical Practice",

issn = "1365-1501",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

AU - Bandelow, Borwin

AU - Sher, Leo

AU - Bunevicius, Robertas

AU - Hollander, Eric

AU - Kasper, Siegfried

AU - Zohar, Joseph

AU - Möller, Hans Jürgen

AU - Thibaut, Florence

AU - Baranska-Rybak, Wioletta

AU - Cubala, Wieclaw J.

AU - Fiellin, David

AU - Kranzler, Henry R.

AU - Moore, Alison

AU - Rankans, Elmars

AU - Rasmussen, Jill

AU - Saitz, Richard

AU - Saravane, Djea

AU - Schlaepfer, Thomas E.

AU - Tang, S. W.

AU - Valius, Leonas

AU - Wong, David

AU - Zhitnikova, Larisa M.

AU - Allgulander, C.

AU - Ayuso-Gutierrez, J.

AU - Baldwin, D.

AU - Bunevicius, R.

AU - Cassano, G.

AU - Fineberg, N.

AU - Gabriels, L.

AU - Hindmarch, I.

AU - Kaiya, H.

AU - Klein, D. F.

AU - Lader, M.

AU - Lecrubier, Y.

AU - Lepine, J. P.

AU - Liebowitz, M. R.

AU - Lopez-Ibor, J. J.

AU - Marazitti, D.

AU - Miguel, E. C.

AU - Oh, K. S.

AU - Preter, M.

AU - Rupprecht, R.

AU - Sato, M.

AU - Starcevic, V.

AU - Stein, D. J.

AU - Van Ameringen, M.

AU - Vega, J.

PY - 2012/6

Y1 - 2012/6

N2 - Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessivecompulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.

AB - Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessivecompulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.

KW - Anxiety disorders

KW - Generalized anxiety disorder

KW - Guidelines

KW - Panic disorder

KW - Pharmacological treatment

KW - Social anxiety disorder

UR - http://www.scopus.com/inward/record.url?scp=84860855073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860855073&partnerID=8YFLogxK

U2 - 10.3109/13651501.2012.667114

DO - 10.3109/13651501.2012.667114

M3 - Review article

C2 - 22540422

AN - SCOPUS:84860855073

SN - 1365-1501

VL - 16

SP - 77

EP - 84

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

IS - 2

ER -

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this